Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

53.29 -0.25 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,400 Today
Via Benzinga
Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?
Moderna shares have declined over the past year amid concerns about post-pandemic vaccine sales. 
Via The Motley Fool
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
Merck & Co Inc (NYSE: MRK) and Moderna Inc (NASDAQ: MRNA) initiated a pivotal Phase 3 randomized V940-001 trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT),... 
Via Benzinga
Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma
From Merck & Co., Inc.
Via Business Wire
Moderna Unusual Options Activity For July 25
Via Benzinga
Where Moderna Stands With Analysts
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030
You might want to get in on this story right now. 
Via The Motley Fool
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
Cathie Wood's Ark Invest bought over $12 million worth of Moderna shares as the biopharma expands its pipeline beyond COVID-19. 
Via Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful. 
Via InvestorPlace
Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute
The Biden administration is reportedly considering lifting sanctions on a Chinese forensic institute allegedly involved in human rights violations. The U.S. is striving to find a way to persuade... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
How Is The Market Feeling About Moderna?
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today
Via Benzinga
Check Out What Whales Are Doing With MRNA
Via Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair  
Via Benzinga
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
William Blair initiated coverage on Moderna Inc (NASDAQ: MRNA) with a Market Perform rati 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go
The recent rally is starting to extend to include large-cap and blue-chip stocks, but there are still some blue-chip stocks to avoid. 
Via InvestorPlace
Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
It helps to offer products everyone needs. 
Via The Motley Fool
Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?
RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment. 
Via InvestorPlace
7 Biotech Stocks to Sell in July
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex shares have advanced about 20% so far this year. 
Via The Motley Fool
EXCLUSIVE: The 20 Most-Searched For Tickers On Benzinga Pro From The First Six Months Of 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to get the latest breaking news on the overall market and individual tickers. 
Via Benzinga
What's Going On With Novavax (NVAX) Stock?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher on Monday after the company announced an amendment to its Canada supply agreement, under which the Government of Canada will pay Novavax $349.6... 
Via Benzinga
Tesla, Netflix And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower on Friday following jobs data for June. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.